KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Return on Sales (2016 - 2025)

Astrana Health's Return on Sales history spans 16 years, with the latest figure at 0.0% for Q3 2025.

  • For Q3 2025, Return on Sales fell 4.0% year-over-year to 0.0%; the TTM value through Sep 2025 reached 0.0%, down 3.0%, while the annual FY2024 figure was 0.02%, 2.0% down from the prior year.
  • Return on Sales for Q3 2025 was 0.0% at Astrana Health, down from 0.02% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.35% in Q2 2021 and bottomed at 0.09% in Q4 2021.
  • The 5-year median for Return on Sales is 0.04% (2024), against an average of 0.04%.
  • The largest YoY upside for Return on Sales was 10bps in 2022 against a maximum downside of -30bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.09% in 2021, then surged by 97bps to 0.0% in 2022, then surged by 91bps to 0.0% in 2023, then tumbled by -4338bps to 0.01% in 2024, then skyrocketed by 110bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Return on Sales are 0.0% (Q3 2025), 0.02% (Q2 2025), and 0.01% (Q1 2025).